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Nowadays, great efforts are made to gain insight into the molecular mechanisms that
underlie structural neuronal plasticity. Moreover, the identification of signaling pathways
involved in the development of psychiatric disorders aids the screening of possible
therapeutic targets. Genetic variations or alterations in GPM6A expression are linked
to neurological disorders such as schizophrenia, depression, and Alzheimer’s disease.
GPM6A encodes the neuronal surface glycoprotein M6a that promotes filopodia/spine,
dendrite, and synapse formation by unknown mechanisms. A substantial body of
evidence suggests that the extracellular loops of M6a command its function. However,
the proteins that associate with them and that modulate neuronal plasticity have not
been determined yet. To address this question, we generated a chimera protein that
only contains the extracellular loops of M6a and performed a co-immunoprecipitation
with rat hippocampus samples followed by TMT/MS. Here, we report 72 proteins,
which are good candidates to interact with M6a’s extracellular loops and modify its
function. Gene ontology (GO) analysis showed that 63% of the potential M6a’s interactor
proteins belong to the category “synapse,” at both sides of the synaptic cleft, “neuron
projections” (51%) and “presynapse” (49%). In this sense, we showed that endogenous
M6a interacts with piccolo, synaptic vesicle protein 2B, and synapsin 1 in mature
cultured hippocampal neurons. Interestingly, about 28% of the proteins left were related
to the “myelin sheath” annotation, suggesting that M6a could interact with proteins at
Abbreviations: BAP, Biotin Acceptor Peptide; CE, Cellular extract; CH3, Human IgG heavy chain constant domain 3;
co-IP, Co-immunoprecipitation; DB, Dot blot; DDA, Data Dependent Acquisition; DIV, Days in vitro; EC1, Extracellular
domain 1 or small extracellular loop; EC2, Extracellular domain 2 or large extracellular loop; FC, Fold change; FDR,
False Discovery Rate; GO, Gene Ontology; GRIN1, N-methyl-D-aspartate receptor type 1; HEK293, Human Embryonic
Kidney cells; HP, Pooled hippocampi; Limma, Linear Models for Microarray Data; MS, Mass spectrometry; N2a, Murine
neuroblastoma N2a cells; NCAM, Neuronal Cell Adhesion Molecule; PCLO, Piccolo; PLP1, Proteolipid Protein 1; PKC,
Protein Kinase C; P, Postnatal day; SEC, Secretion sequence; SN, Supernatant; SV2B, Synaptic vesicle protein 2B; SYN1,
Synapsin 1 protein; TMT, Tandem Mass Tag; TMT/MS, Tandem mass tag spectrometry identification; TRFC, Transferrin
receptor; WB, Western blot.
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the surface of oligodendrocytes. Indeed, we demonstrated the (cis and trans) interaction
between M6a and proteolipid protein (PLP) in neuroblastoma N2a cells. Finally, the
72 proteins were subjected to disease-associated genes and variants screening by
DisGeNET. Apart from the diseases that have already been associated with M6a,
most of the proteins are also involved in “autistic disorder,” “epilepsy,” and “seizures”
increasing the spectrum of disorders in which M6a could play a role. Data are available
via ProteomeXchange with identifier PXD017347.
Keywords: synaptic proteins, rat hippocampal neurons, mass spectometry, protein-protein interaction, proteolipd
protein family
GRAPHICAL ABSTRACT | Sunburst plot from SynGO analysis of M6a’s potential synaptic interactors (https://www.syngoportal.org/, Koopmans et al.,
2019). This work shows a combination of co-immunoprecipitation assay with quantitative tandem mass tag spectrometry (TMT/MS) to identify potential protein-
protein interactions. Using a chimera protein that only contains the extracellular loops of neuronal glycoprotein M6a, we performed a co-IP with rat hippocampi
samples followed by TMT/MS. Data analysis revealed 72 potential interactors of M6a’s loops, 45 of which are related to synapse localization.
INTRODUCTION
The membrane glycoprotein M6a—together with proteolipid
protein PLP1, DM20, and M6b—belongs to the tetraspan
PLP family (Schweitzer et al., 2006). M6a is a neuronal
surface protein that promotes neuronal stem cell differentiation,
migration, neurite outgrowth, filopodia/spine induction, and
synapse formation in primary neuronal cultures and (non-)
neuronal cell lines (Alfonso et al., 2005; Michibata et al.,
2008; Zhao et al., 2008; Michibata et al., 2009; Formoso
et al., 2015a,b, 2016; Garcia et al., 2017; Honda et al.,
2017). In humans, alterations in M6a levels or polymorphisms
in GPM6A, are associated with depression, schizophrenia,
claustrophobia, bipolar disorders, and learning disabilities
(Boks et al., 2008; Greenwood et al., 2012; El-Kordi et al., 2013;
Gregor et al., 2014; Fuchsova et al., 2015). In mice, variations
in Gpm6a expression are linked to chronic stress/depression,
claustrophobia, and Alzheimer’s disease (Alfonso et al., 2005;
El-Kordi et al., 2013; Lachén-Montes et al., 2016). Nevertheless,
the complete mechanism by which M6a participates in
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synaptic plasticity and how it is linked to disease onset
remains unknown.
According to topology predictions, M6a and PLP family
members share structural similarity with the tetraspanin
family, containing four transmembrane domains (TMs), two
extracellular loops (EC1 and EC2), an intracellular loop
(IC) and their N- and C-terminus facing the cell cytoplasm
(Figure 1A). Tetraspanins are ubiquitous molecules involved
in cell adhesion, migration, proliferation, and differentiation
via cell-cell, matrix–cell and lateral associations in the plasma
membrane. Each tetraspanin can interact with a group of partner
proteins in a dynamic assembly forming tetraspanin-enriched
microdomains (TEMs), which represent functional platforms
(Yáñez-Mó et al., 2009; Scorticati et al., 2011). Thus, the
specific tetraspanin functions in different cell types depending on
their heterotypic association—within the TEMs—with different
partner proteins. In this regard, a large number of different
partner molecules might explain why tetraspanins are involved
in such a wide variety of essential cellular processes. Mutagenesis
studies of the extracellular loops of tetraspanins demonstrated
that they are crucial for the specificity of protein-protein
interactions. Particularly, the EC2 contains all of the known
tetraspanin protein-protein interaction sites, and monoclonal
antibodies that recognize cell surface epitopes so far exclusively
recognize the EC2 domain. Whereas the EC1 is necessary for
correct surface expression of the protein and it is responsible for
EC2-interactor binding strength (Murru et al., 2018).
Regarding M6a, there is strong evidence suggesting that
M6a’s extracellular loops contribute to its function. For instance,
hippocampal neurons exposed to the monoclonal structural
antibody (M6a-mAb), which recognizes M6a’s extracellular
loops, arrests neurite extension and synapse formation (Lagenaur
et al., 1992; Formoso et al., 2015a; Garcia et al., 2017). The
M6a-mAb treatment induces M6a’s endocytosis and sorting
to degradation compartments leading to plasticity impairment.
Moreover, certain cysteine residues within the EC2 of M6a are
FIGURE 1 | Workflow: from the chimera protein to co-immunoprecipitation and protein identification. (A) Schematic representation of M6a: it has four
transmembrane domains (TM1-4), two extracellular loops, a small (EC1) and a large (EC2), an intracellular loop (IC) and the N- and C-terminus at the cell cytoplasm.
(B) Scheme of the chimera protein: M6a-loops construct. The EC1 and EC2 of rat M6a (NCBI Reference Sequence: NP_835206.1), were cloned into the pBig
plasmid. White box: CMV promoter, blue box: secretion signal peptide, SEC, red boxes: EC1, EC2, and the polylinker peptide, orange box: IgE secretion sequence,
green box: SV5 tag and pink box: biotin acceptor peptide (BAP) tag. (C) M6a-loops-HEK293 cells were labeled with structural anti-M6a-mAb (magenta),
anti-SV5-mAb (green), and the superposition of both channels is shown in white (Merge). Cells nuclei were stained with DAPI. Scale bar: 30 µm. (D) Representative
Western blots (top panels) and Dot blot (DB, bottom panel) of cell extracts (CEs) and concentrated supernatants (SN) from M6a-loops-HEK293 cells and culture
media respectively. Non-transfected HEK293 cells were used as the negative control. Rat hippocampi homogenates were used as a positive control in DB.
Anti-SV5-mAb and Streptavidin-HRP were used to characterize the expression and secretion of M6a-loops. DB was done under non-denaturing conditions and 1 µl
and 5 µl of M6a-loops from SN (0.5 mg/ml) were used. (E) Representative Western blot of rat hippocampus from postnatal day 0 (P0) to P30. Primary antibodies
used were anti-M6a:COOH and anti-tubulin as the loading control. (F) Workflow of the co-IP-TMT/MS experiment. M6a-loops was captured with anti-SV5-mAb
cross-linked into protein A magnetic beads. After, protein extracts from rat hippocampi homogenates of postnatal days 14, 21, and 30 (n = 3 animals per co-IP, one
animal of each P day per experiment) were co-immunoprecipitated with M6a-loops. A total of three co-IPs were performed with their replicates (n = 9). Eluted
proteins were enzymatically digested and peptides were subjected to TMT/MS. Finally, we performed data analysis, gene ontology (GO) enrichment analysis, and
validation of these results.
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functionally crucial sites for its folding and filopodia induction
(Fuchsova et al., 2009). In summary, we and other groups
proved the functional relevance of M6a’s extracellular loops in
neuronal plasticity (Baumrind et al., 1992; Lagenaur et al., 1992;
Mukobata et al., 2002; Fuchsova et al., 2009; Sato et al., 2011;
Formoso et al., 2015a; Garcia et al., 2017). Hence, we hypothesize
that the broad range of M6a’s functions depends on specific
interactions through its extracellular loops in each particular
cell and throughout each stage of development. Several proteins
are involved in M6a mechanisms of action, such as protein
kinase C (PKC), neuronal cell adhesion molecule (NCAM),
Src family of tyrosine kinases, clathrin, ruffy-3, coronin-1A, N-
methyl-D-aspartate receptor type1 (GRIN1), and synaptophysin.
However, most of them are associated withM6a cytoplasmic tails
(Mukobata et al., 2002; Scorticati et al., 2011; Fuchsova et al.,
2015; Alvarez Juliá et al., 2016; Formoso et al., 2016; Garcia et al.,
2017; Honda et al., 2017). Hence, the proteins that might interact
with the extracellular loops of M6a and potentially control its
function have not been determined yet. Here, to identify M6a’s
extracellular loops partners, we designed and purified a chimera
protein—containing both loops of M6a—and used it as bait in
a co-immunoprecipitation assay (co-IP) followed by quantitative
tandem mass tag spectrometry (TMT/MS; Figure 1F). Analysis
of the 1,529 identified proteins revealed that 72 proteins, with
a high degree of stringency, could be associated with M6a.
Moreover, functional enrichment analysis by gene ontology
(GO) showed that most proteins are involved in neuronal
plasticity at the synapse level. We were able to confirm three
proteins (piccolo, synapsin 1, and synaptic vesicle glycoprotein
2B) which colocalized with M6a at the synaptic boutons and may
have a crucial role in M6a-induced plasticity. Interestingly, we
report that M6a can interact with PLP, suggesting a new role
of M6a in neuron-glia interaction. Moreover, we interrogated
the DisGeNET database and most of the enriched proteins were




Pregnant Sprague–Dawley rats maintained at the Facultad de
Farmacia y Bioquímica of the Universidad of Buenos Aires
(FFyB-UBA) were used. All animal procedures were carried out
according to the guidelines of the National Institutes of Health
(publications No. 80-23) and approved by the Committee for the
Care andUse of Laboratory Animals of the UniversidadNacional
de San Martín (CICUAE-UNSAM).
Primary cultures of hippocampal neurons were prepared from
fetal rats at embryonic day 19 (CICUAE-UNSAM No. 03/2015,
see also ‘‘Cell Culture’’). On the other hand, litters from two
female Sprague–Dawley rats were used for co-IP experiments.
The pups were housed with their mother in individual cages
until weaning on day 21. The animals were cared for according
to the protocol of CICUAE-UNSAM No. 03/2016. During
all experiments, animals were kept at the IIBio-UNSAM lab
animal facility. All animals had free access to food and water
and were maintained in a 12/12 h dark/light cycle. The pup’s
age was determined as life-days after birth, the day of birth
was considered as postnatal day zero (P0) and the subsequent
days as P1 to P30. The litters were randomly allocated in
three independent co-IP experiments.
Reagents and Antibodies
Primary antibodies were: monoclonal anti-M6a rat IgG (M6a-
mAb, 1/1,000; Medical and Biological Laboratories, MBL,
Nagoya, Japan), polyclonal rabbit anti-C terminus of M6a (anti-
M6a:COOH, 1/750) developed in our laboratory (Scorticati
et al., 2011), monoclonal mouse anti-alpha-tubulin (anti-
Tub, 1/1,000; Sigma, Munich, Germany), monoclonal mouse
anti-SV5 tag IgG2a (anti-SV5-mAb, 1/1,000; Invitrogen, Leiden,
Netherlands), polyclonal rabbit anti synapsin 1 (anti-Syn1, 1/500;
Chemicon International, Temecula, CA, USA), monoclonal
mouse anti-human transferrin receptor (anti-TfR, 1/500; Zymed
Laboratories, San Francisco, CA, USA), polyclonal rabbit anti
synaptic vesicle protein 2B (anti-SV2B, 1/200), polyclonal rabbit
anti piccolo (anti-PCLO, 1/200; Synaptic Systems, Göttingen,
Germany). Secondary antibodies were: rhodamine-conjugated
goat anti-rat IgG (H + L; 1/1,000; Jackson ImmunoResearch
Laboratories, West Grove, PA, USA) and preabsorbed secondary
antibodies: Alexa 488 goat anti-rabbit IgG (H + L; 1/1,000),
Alexa 488 goat anti-mouse IgG (H + L; 1/1,000; Invitrogen,
Oregon, USA). Antibodies HRP-conjugated were: polyclonal
goat anti-rabbit IgG (1/16,000; Sigma, St. Louis, MO, USA) and
polyclonal goat anti-mouse IgG (1/5,000; Sigma, Saint Louis,
MO, USA).
Other reagents used were: 4′,6-Diamidino-2-
phenylindole dihydrochloride (DAPI, Sigma), biotin (Sigma),
streptavidin-HRP conjugated (BD Bioscience, San Jose, CA,
USA), protein A/G-HRP conjugated (Thermo Fisher Scientific,
Waltham, MA, USA), protease inhibitor cocktail (PIC, Sigma),
lipofectamine LTX with Plus reagent (Thermo Fisher Scientific,
Waltham, MA, USA), trypsin, sequencing grade (Promega,
Fitchburg, WI, USA) and paraformaldehyde 16% solution (PFA;
Electron Microscopy Sciences, Hatfield, PA, USA).
Plasmids
To identify proteins that could interact with the extracellular
loops of M6a, we designed a chimera protein called M6a-loops.
The amino acid sequence for M6a-loops contains the small (EC1,
44-84) and large (EC2, 149-213) extracellular loops of rat M6a
(NCBI Reference Sequence: NP_835206.1), both linked by a
linker peptide (GGGGS). A secretion sequence, SEC, was fused
to the N-terminus of the EC1 according to (Predonzani et al.,
2008). At the C terminus of the EC2, the human IgG heavy chain
constant domain 3 (CH3) sequence was added, as this sequence
was described as an enhancer of secretion of recombinant
proteins (Poggianella et al., 2015). The final DNA sequence
of M6a-loops was synthesized by GeneScript and cloned into
the HindIII and KpnI sites of the pUC18 plasmid. Then, the
M6a-loops sequence was sub-cloned into the pBig-BirA-SV5-
biotin acceptor peptide (BAP; pBig) plasmid (Predonzani et al.,
2008). pBig, a single bigenic plasmid, has two different and
independent gene cassettes. The first one codifies the sec-BirA
enzyme, which recognizes and biotinylates a BAP. The second
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cassette has two tags: an Sv5 tag sequence and the BAP sequence.
M6a-loops sequence was inserted into the second cassette of the
pBig plasmid, upstream the Sv5 tag sequence (Figure 1B).
For green fluorescent protein (GFP) or red fluorescent protein
(RFP)-tagged proteins, a plasmid encoding for GFP/RFP (EGFP-
C1 and RFP-C1; Clontech Laboratories, Palo Alto, CA, USA)
fused in frame with the coding sequence of mouse PLP and
mouse M6a were used (Fernández et al., 2010; Formoso et al.,
2015a). GFP-tagged transferrin (Trf-GFP) was kindly supplied
by Dr. Juan S. Bonifacino’s lab (NIH, Bethesda, MD, USA;
Rodriguez-Walker et al., 2015).
Cell Culture and Plasmid Transfection
Hippocampal Cultures
Dissociated neuronal cultures were prepared from rat
hippocampi of embryonic day 19, as previously described
(Formoso et al., 2015a). Briefly, tissues were treated with 0.25%
trypsin in Hanks’ solution at 37◦C for 15 min. A single-cell
solution was prepared in Neurobasalr medium (NB, Invitrogen)
containing 2 mM glutamine (Sigma), 1 mg/ml gentamicin
(Sigma) with 10% (v/v) horse serum (Gibcor, Thermo Fisher
Scientific, Waltham, MA, USA). Cells were seeded on coverslips
coated with 0.1 mg/ml poly-L-lysine hydrobromide (Sigma) and
20 mg/ml laminin (Invitrogen) at a low density of 7,000 cells per
well into a 24-well plate. After 2 h, the medium was changed
to NB (NB1X with 1 g/L ovalbumin and B27 serum-free
supplements from Invitrogen). Neurons were cultured for
12–15 days (DIV) and based on morphological characteristics,
we estimated that more than 90% of the cells in the cultures
were neurons.
Cell Lines
Human embryonic kidney cells (HEK293) cells were cultured
in Dulbecco’s modified Eagle’s medium (DMEM, Gibco)
supplemented with high glucose 0.35% (m/v), 200 mM L-alanine
L-glutamine (GlutaMAX, Invitrogen), 10% (v/v) fetal bovine
serum (FBS, Gibco) and 1 mg/ml gentamicin. Stable M6a-loops-
HEK293 clones were selected with 0.4 mg/ml G418 (Sigma)
according to protocols described in Wurm (2004).
For colocalization assays, murine neuroblastoma N2a cells
were cultured in DMEM with 20% (v/v) FBS and 1 mg/ml
gentamicin. Cells were seeded on coverslips in 24-well plates
and then transiently co-transfected with M6a-GFP/RFP and with
PLP-GFP or Tfr-GFP with Lipofectamine LTX with Plus reagent
according to the manufacturer’s instructions (Thermo Fisher
Scientific, Waltham, MA, USA).
Protein Expression and Purification
Stable M6a-loops-HEK293 cells were cultured and maintained
as described, in a T175 flask until confluence. Then, the
culture medium was replaced with a serum-free medium
supplemented with 100 mM biotin (Sigma). After 72 h, culture
supernatant (SN) and CEs were collected. SN samples, having
M6a-loops in solution, were filtered with a 0.45 µm filter
and then concentrated to a final volume of 1.0–1.5 ml by
consecutive rounds of centrifugation at 1,500 g for 40 min at
4◦C using a Centripep, centrifugal filter device (3 kDa pore
membrane, Amicon-Millipore Corporation). Then, SN’s protein
concentration was measured by NanoDrop One (Thermo). CE
samples were collected with a scrapper, centrifuged at 1,500 rpm
for 5 min, and re-suspended in 150 µl of Triton X-100 0.1%
in PBS with PIC. Then, CE samples, having a retained fraction
of M6a-loops, were sonicated and pelleted by centrifugation
(15,000 g for 10 min at 4◦C).
Immunocytochemistry
For endogenous M6a staining, cells (M6a-loops-HEK293 cells
and hippocampal neurons) were incubated for 1 h at 4◦C with
anti-M6a mAb (1 mg/ml) in fresh medium. Afterward, cells were
washed with PBS and labeled with rhodamine-conjugated goat
anti-rat IgG (H + L; 1/1,000) for 1 h at 4◦C. Then, cells were
fixed in 4% paraformaldehyde and 4% sucrose in PBS at room
temperature for 10 min. Next, cells were permeabilized with 0.1%
Triton X-100 in PBS for 5 min and blocked with 3% bovine
serum albumin (BSA) in PBS for 1 h. Cells were labeled with
primary antibodies in 3% BSA for 16 h at 4◦C. The next day,
cells were labeled with preabsorbed secondary antibodies: Alexa
fluor 488 goat anti-mouse or Alexa fluor 488 goat anti-rabbit
(1/1,000) for 1 h at room temperature. Then, nuclei were stained
with DAPI (1/5,000) for 5 min at room temperature. Coverslips
were mounted in Fluorsave r (Calbiochem).
In the case of M6a-RFP and PLP-GFP or TfR-GFP expressing
cells, the coverslips were washed, fixed, and mounted.
Image Analysis
For characterization of the chimera protein, M6a-loops-
HEK293 cells were imaged with a 1.4 NA, 60× objective lens on a
Nikon Eclipse TE2000 inverted microscope coupled to an ORCA
II ER CCD camera controlled by Metamorph 6.1 software. For
colocalization analysis, cells were imaged at a 60× objective lens
with a numeric aperture of 1.42 on an Olympus FV1000 confocal
microscope. We set up the Olympus Fluoview v3.1a software
to acquire the images with a 4–10 µs/pix of dwell time. We
manually adjusted the laser energy setting (HV, gain and offset)
by using slides stained only with the secondary antibodies to
determine the threshold of background signal, which was applied
to each image of the experiment. For colocalization cell images
were in raster scan mode satisfying the Nyquist criterion, pixel
size was 2–3 times smaller than the object.
The colocalization of puncta between M6a and pre-synaptic
markers (piccolo, SV2B, and synapsin 1) was assessed in
approximately 10–15 neurons per condition. The selected
neurons were at least two cell diameters away from their nearest
neighbor. The colocalization of puncta was determined using
the plugin Puncta Analyzer from ImageJ (NIH) as previously
described (Ippolito and Eroglu, 2010; Formoso et al., 2016).
Briefly, three regions of interest (25 µm of dendrite length)
from each neuron were selected, and then the background
was subtracted. The threshold was adjusted manually for each
channel. The minimum puncta size was set to four pixels. For
each neuron analyzed, the number of puncta colocalization of the
three segments were measured and averaged. Data are expressed
as the average of synaptic puncta ± SEM. Three independent
experiments were performed.
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Estimation of colocalization betweenM6a and PLP or TfRwas
performed with the Coloc2 plugin of ImageJ. Coloc2 calculated
Pearson’s correlation coefficient above the threshold for each pair
of proteins and ranges between −1 and 1. Pearson’s coefficient
higher than 0.5 was considered positive for colocalization.
Mander’s coefficients above the threshold M1 (for channel 1,
green) andM2 (for channel 2, red) were quantified for those pairs
with a Pearson’s greater than 0.5 in the selected region of interest
(three ROIs per cell). The average of each Mander’s coefficient
was calculated and plotted. M1 andM2 estimate the fluorescence
intensity of the two colors that overlap in a pixel from the PLP
or TfR image to M6a and vice versa, respectively. A coefficient
close to one indicates a high overlap of the signals (Formoso
et al., 2015b). Data are expressed as the average of Pearson’s
coefficient± SEM.
Images were processed in Adobe Photoshop (version 8.0.1;
Adobe Systems, San Jose, CA, USA).
Western Blotting
Supernatant concentrated samples and whole-cell lysates were
processed in the presence of PIC. Samples containing an equal
amount of protein from rat hippocampi at different postnatal
age, SN, and CE were analyzed under reducing conditions in a
10% SDS-PAGE. After electrophoresis, proteins were transferred
onto a nitrocellulose membrane (Millipore) in a tank blot
apparatus (Bio-Rad Laboratories). Membranes were blocked in
Tris-buffered saline (TBS) solution containing 5% non-fat dried
milk for 1 h at room temperature and incubated with primary
antibodies diluted in 1% BSA-PBS overnight at 4◦C. The next
day, membranes were washed with TBS-T (TBS–0.2% Tween 20)
and incubated with HRP-conjugated antibodies for 2 h at room
temperature. To detect biotinylatedM6a-loops, membranes were
blocked overnight with 5% BSA-TBS at 4◦C. The next day,
membranes were incubated with streptavidin-HRP for 2 h at
room temperature. Antigen-antibody complexes were detected
according to a standard Enhanced Chemiluminescence blotting
protocol using Super Signal Chemiluminescent Substrate (ECL-
Pierce) and CL—Xposure films (Thermo Fisher Scientific,
Waltham, MA, USA).
Dot Blotting
To determine whether M6a-loops in SN samples were correctly
folded, we performed a dot blot (DB) assay under native
conditions. Two spots of 1 µl and 5 µl of SN (0.5 mg/ml)
were placed on a PVDF membrane (Hybond-P, Amersham Life
science), activated according to the manufacturer’s instructions.
Non-specific sites were blocked with 1% BSA diluted in TBS
for 1 h at room temperature. Afterward, membranes were
incubated with anti-M6a-mAb overnight at 4◦C. The next day,
the membrane was washed three times with 0.1% BSA diluted
in TBS for 5 min each and incubated with anti-G protein HRP
conjugated for 1 h at room temperature. The antigen-antibody
complexes were detected as described above.
Co-immunoprecipitation
Three independent co-IPs, between M6a-loops and pooled rat
hippocampi (HP), were performed. Briefly, nine hippocampi
from P14 (n = 3), P21 (n = 3), and P30 (n = 3) rats were
dissected and resuspended separately in 100 µl of Triton X-100
1% in PBS with PIC. Then, the nine samples were sonicated
and pelleted by centrifugation (15,000 g for 10 min at 4◦C).
For each independent co-IP, each pool was composed of a
combination of hippocampi from the three different ages. In
other words, a total of nine individuals were sacrificed at different
postnatal days, split and pooled in three different Co-IP samples.
Pooled hippocampi samples were clarified (HPc) using 200 µl
of protein A magnetic beads (SureBeadsTM, BioRad) for 2 h at
room temperature under rotation. Then, two conditions were
tested: a mock condition (Mock_1–3) and the co-IP condition
(co-IP 1–3, with two experimental replicates R1–2). For the co-
IPs, the anti-SV5 tag-mAbwas chemically cross-linked to protein
A magnetic beads. Then, 10–25 µg of M6a-loops obtained from
SN samples were incubated with the anti-SV5-magnetics beads
(co-IP) or with protein A magnetic beads only (Mock) for 1 h
at room temperature under rotation. Afterward, each condition
was incubated with HPc (200–350 µg) overnight at 4◦C under
rotation. The table below summarizes each condition and the
reagents used for each co-IP assay.
On the next day, samples were washed three times with PBS-
T, and protein complexes were eluted with 50 µl of SDS-buffer
with dithiothreitol (DTT) 10 mM and boiled for 10 min.
Sample Preparation and Mass
Spectrometry Data Acquisition and
Analysis
Sample Preparation and TMT Labeling
The nine final samples were sent to the Proteomic Core
Facility of the European Molecular Biology Laboratory (EMBL,
Heidelberg). The reduction of disulfide bridges in cysteine-
containing proteins was performed with 10 mM DTT diluted in
50 mM HEPES, pH 8.5 for 30 min at 56◦C. Reduced cysteines
Co-immunoprecipitation assay
Samples Protein A magnetic beads anti-SV5 tag batch M6a-loops HPc
1 Mock 1 50 µl X 20–25 µg/each Pool 1: 350 µg/each
co-IP1 R1 50 µl 7, 5 µg/Batch #1905424
co-IP1 R2 50 µl
2 Mock 2 50 µl X 10–15 µg/each Pool 2: 200 µg/each
co-IP2 R1 50 µl 5 µg/Batch #1222254
co-IP2 R2 50 µl
3 Mock 3 50 µl X 10–15 µg/each Pool 3: 350 µg/each
co-IP3 R1 50 µl 5 µg/Batch #1905424
co-IP3 R2 50 µl
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were alkylated with 20 mM 2-chloroacetamide diluted in HEPES
for 30 min at room temperature in the dark. Samples were
prepared using the SP3 (Hughes et al., 2019). Digestion of
samples was done with trypsin, in an enzyme to protein ratio
1:50 overnight at 37◦C. The next day, peptide recovery was
done in HEPES buffer by collecting supernatant on the magnet
and combining with the second elution wash of beads with
HEPES buffer.
Peptides were labeled with TMT10plex Isobaric Label Reagent
(ThermoFisher) according to the manufacturer’s instructions
(Werner et al., 2014). Briefly, 0.8 mg of TMT reagent was
dissolved in 42 µl acetonitrile (100%) and 4 µl of stock
was added and incubated for 1 h at room temperature.
Then, the reaction was quenched with 5% hydroxylamine for
15 min and the digested co-IP samples were combined for
the TMT10plex. For further sample clean up, an OASISr
HLB µElution Plate (Waters) was used. Offline high pH
reverse phase fractionation was carried out on an Agilent
1200 Infinity high-performance liquid chromatography system,
equipped with a Gemini C18 column (3 µm, 110 Å,
100× 1.0 mm, Phenomenex).
Mass Spectrometry Data Acquisition
An UltiMate 3000 RSLC nano-LC system (Dionex) fitted with
a trapping cartridge (µ-Precolumn C18 PepMap 100, 5 µm,
300 µm i.d. × 5 mm, 100 Å) and an analytical column
(nanoEaseTM M/Z HSS T3 column 75 µm × 250 mm C18,
1.8 µm, 100 Å, Waters) was used. Samples were trapped with
a constant flow of 0.1% formic acid in water (Solvent A) at
30 µl/min onto the trapping column for 6 min. Subsequently,
peptides were eluted via the analytical column with a constant
flow of 0.3 µl/min with an increasing percentage of 0.1% formic
acid in acetonitrile (Solvent B) from 2% to 4% in 4 min, from
4% to 8% in 2 min, then 8% to 28% for a further 96 min,
and finally from 28% to 40% in another 10 min. The outlet
of the analytical column was coupled directly to a QExactive
plus (Thermo Fisher Scientific, Waltham, MA, USA) mass
spectrometer using the Proxeon nano-flow source in positive
ion mode.
After, peptides were introduced into the QExactive plus via
a Pico-Tip Emitter 360 µm OD × 20 µm ID; 10 µm tip (New
Objective), and an applied spray voltage of 2.3 kV. The capillary
temperature was 320◦C. The full mass scan was acquired with a
mass range of 375–1,200 m/z in profile mode with a resolution
of 70,000. The filling time was set at a maximum of 10 ms with
a limitation of 3 × 106 ions. Data-dependent acquisition (DDA)
was performed with the resolution of the Orbitrap set to 35,000,
with a fill time of 120 ms and a limitation of 2 × 105 ions. The
normalized collision energy of 32 was applied and the dynamic
exclusion time of 30 s was used. The peptide match algorithm
was set to ‘‘preferred’’ and charge exclusion ‘‘unassigned,’’
charge states 1, 5–8 were excluded. MS2 data were acquired in
profile mode.
MS Data Processing
The raw data were acquired and processed with IsobarQuant and
Mascot (v2.2.07) respectively (Franken et al., 2015). The data
was processed against the Uniprot Rattus norvegicus proteome
database (ID: UP000002494, downloading date: 05142016,
number of entries: 31673, including common contaminants,
keratins and reversed sequences). The following modifications
were included in the search parameters: Carbamidomethyl (C)
and TMT10 (K; fixed modification), Acetyl (Protein N-term),
Oxidation (M) and TMT10 (N-term; variable modifications).
For the full scan (MS1), a mass error tolerance of 10 ppm
and for MS/MS (MS2) spectra of 0.02 Da was set. For protein
identification, these parameters were also required: trypsin as
protease (with an allowance of maximum two missed cleavages);
seven amino acids as minimum peptide length and at least two
unique peptides for the same protein. The false discovery rate
(FDR) on peptide and protein level was set to 0.05.
Differential Protein Analysis
The protein.txt output files of IsobarQuant were processed
with the R programming language (Team, 2008). To ensure
data quality, only proteins that were quantified with at least
two unique peptides were considered for the analysis. In total,
1,529 proteins passed this quality step. The TMT reporter ion
intensities (signal.sum columns) were first cleaned for batch-
effects using the ‘‘removeBatchEffect’’ function of the Limma
package and further normalized using variance stabilization
normalization (Huber et al., 2002). Different normalization
coefficients were estimated for the ‘‘mock’’ condition to account
for the lower protein amount. Proteins were tested for differential
expression with a moderated t-test using the Limma package.
The replicate factor was included in the linear model. A protein
was annotated as a ‘‘hit’’ with a fold-change of at least 2-fold
and an FDR below 0.05 and annotated as a ‘‘candidate’’ with a
fold-change of at least 1.5-fold and an FDR below 0.2.
Gene Ontology Analysis
The list of identified proteins was manually-curated based
on literature (Végh et al., 2014; Jacquemet et al., 2019; Lleó
et al., 2019) and their subcellular localization according to the
UniProt database1. Proteins from the nucleus, cytosol, organelles,
and membrane proteins from the cytosolic side of the cell
were excluded. Proteins secreted, established in the extracellular
matrix, plasma membrane and synaptic vesicles were selected for
the enrichment analysis. GO enrichment and gene prioritization
were made using the ToppFun application of ToppGene Suite
server2 (Chen et al., 2009).
Statistical Analysis
All data were processed with the R programming language
(Team, 2008)3. For differential protein expression analysis
between conditions, a t-test was used and applied with Linear
Models for Microarray Data (Limma) package (Ritchie et al.,
2015). Two-tailed Pearson correlation coefficient (r) between
biological replicates of total identified proteins per co-IP was
calculated. Considering positive and significant correlation
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RESULTS
Design and Characterization of a
Recombinant Bait Protein
Co-immunoprecipitation in combination with mass
spectrometry is a powerful tool to identify potential protein-
protein interactions (Sommer et al., 2014). Thus, to elucidate
endogenous proteins that could potentially interact with
M6a’s extracellular loops we first cloned a chimera protein
containing both extracellular loops of M6a (M6a-loops) in a
bigenic plasmid (pBig). The pBig plasmid has two different
and independent gene cassettes: one for the sec-BirA enzyme
(which biotinylates proteins in a specific amino acid sequence)
and the other for the target protein. Figure 1B shows a
schematic representation of the fusion protein cloned into
pBig plasmid: M6a-loops is followed by the secretory peptide
sequence of IgE (CH3), SV5 tag, and the BAP (Predonzani
et al., 2008). We first determined whether M6a’s loops could
be expressed and folded properly in the chimera protein.
For that purpose, M6a-loops expressing HEK293 cells were
incubated with a structural M6a-mAb antibody for 45 min at
4◦C. Afterward, the cell surface was labeled with secondary
rhodamine-conjugated antibodies (shown in magenta) and
then fixed, permeabilized, blocked, and labeled with an anti-
SV5-mAb antibody (shown in green). Figure 1C shows the
binding features of M6a-loops in the cell surface of stable
M6a-loops-expressing cells (M6a-loops-HEK293 cells). An
overlap of both magenta and green signals was observed all
along the cell surface, demonstrating that our recombinant
protein was properly folded and expressed the SV5 tag. The
staining pattern of non-transfected HEK293 cells is shown in
Supplementary Figure S1. Concentrated supernatants-SN-
and cell extracts-CE- from M6a-loops-HEK293 cells were
then analyzed by immunoblots. Streptavidin-HRP tagged and
anti-SV5-mAb antibodies were used to verify whether both
samples express the chimera. Figure 1D shows a representative
Western blot in which a unique band of approximately 36 kDa
was recognized by anti-SV5-mAb and streptavidin-HRP
in both CE and SN. Intact HEK293 cells were used as a
negative control.
As we mentioned, M6a-mAb is a structural monoclonal
antibody that recognizes conformational epitopes at M6a’s
extracellular loops (Lagenaur et al., 1992). Thus, we performed
a DB under non-denaturing conditions with SN samples
from M6a-loops-HEK293 cells (Figure 1D, bottom panel).
We also used SN samples from intact HEK293 cells and
homogenates of rat hippocampus as negative and positive
controls respectively. A positive signal was observed with 1 µl
and 5 µl of SN (0.5 mg/ml) from M6a-loops-HEK293 cells,
which indicates that M6a-loops was correctly folded in the
SN samples. Non-denatured hippocampus sample showed a
positive dot spot compared with the negative sample from
intact HEK293 cells. In summary, we successfully generated a
stable cell line that expresses and secretes a biotinylable chimera
protein, M6a-loops, tagged with SV5, and recognized by the
structural M6a-mAb.
The following step was to obtain the best sample in which
to perform the co-immunoprecipitation. The level of proteins
involved in synapse and dendritic spine formation varies during
extra-uterine brain development (Penzes et al., 2013). It is
well known that glycoprotein M6a exhibits strong expression
in the rat hippocampal formation in association with synapse
development and maintenance (Cooper et al., 2008; Formoso
et al., 2016; Garcia et al., 2017). Thus, we first assessed whether
rat hippocampus M6a expression changes from birth (postnatal
0, P0) up to adulthood (P30). Samples of each condition
were subjected to SDS-PAGE followed by Western blotting
using an anti-M6a antibody, which recognizes the C-terminus
of the protein, and anti-tubulin as a loading control. As
it can be observed in Figure 1E, M6a expression increases
during hippocampus development and exhibits a maximum
between P14-P30.
Proteomics Analysis
For the proteomic study, three independent co-IP experiments
were performed as described in the materials and methods
section. For hippocampi sampling, we took into consideration
two main aspects: the intrinsic variability between different
animals and ages and the minimum amount of protein needed
to perform co-IP experiments (van der Geer, 2014; Bonifacino
et al., 2016). Hence, for each co-IP assay, nine pups from P14,
P21, and P30 were sacrificed and hippocampi were collected
and pooled (HP, see ‘‘Material and Methods’’ section). Then,
HP samples were clarified and subjected to three independent
co-IPs using M6a-loops captured with anti-SV5-mAb in the
surface of protein A magnetic beads. HPc samples incubated
with M6a-loops and protein A magnetic beads were used as
Mock conditions. All samples were eluted and then subjected
to tandem mass spectrometry identification (TMT/MS). Protein
digestion, TMT labeling, fractioning and protein identification
were performed for whole samples in the same run to minimize
inter-assay variation (Figure 1F).
Only proteins that were quantified with at least two unique
peptide matches were kept for the analysis. Moreover, proteins
were kept only if they were quantified in at least 2/3 of
the independent experiments. In Supplementary Table S1 we
summarize the total 1,529 identified proteins that passed these
quality filtration steps, with their corresponding maximum
number of peptides recognized in one run. The raw signal data
obtained (Figure 2A) were subjected to batch effect removal,
data transformation, and logarithmic fold changes (log2FC)
calculation for ulterior comparison (Figure 2B). From the
quantitative proteomic data, we performed Limma analysis
which allowed us to identify differentially immunoprecipitated
peptides/proteins between conditions. The Pearson correlation
coefficient between log2FC of biological replicates was r
0.751 (p < 0.0001; Figure 2C). Therefore, we averaged the
two replicates within each independent co-IP assay and plotted
the log2FC against the log of the total peptide intensity
(average.top3), which can be used as a proxy for absolute
protein abundance (Figure 2D and Supplementary Table S2).
The highest-ranked proteins, proteins whose average of the
relative abundance of their three best peptides (average.top3)
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FIGURE 2 | Data transformation and analysis of differentially immunoprecipitated proteins per condition. (A) Raw intensity signal data from the TMT/MS assay. The
Log2 of the raw intensity signal data is represented for each identified protein in each control (Mock 1-3) and experimental condition with their replicate
(co-IP1-3R1-2). (B) Raw signal data after batch effect removal and data transformation. The plot shows the Log2 of the control ratio for each protein identified in
each experimental condition after being processed. (C) Correlation between replicates for each co-IP experiment. The plot shows the Log2 of the fold change
(Log2FC) for each identified protein in replicate 1 vs. replicate 2. The Pearson correlation between the two replicates is 0.751 (p < 0.0001). (D) Analysis of
differentially immunoprecipitated proteins between Mock and co-IP conditions. The plot shows the Log2FC vs. the total peptide abundance; where the Average.Top3
is the average intensity for the three most abundant peptides of an individual protein and the denominator is the sum of all Top3 values in a condition. Proteins with a
Log2FC ≥2 and an Average.Top3 ≥7 represents the optimal interacting proteins, which were used for further analysis. Proteins highlighted with cream dots have
already been functionally related to M6a. Proteins highlighted with green dots and blue dots were selected for ulterior proteomic validation.
was greater than 7 and with a log2FC of at least two were kept
for further analysis (Werner et al., 2014; Franken et al., 2015;
Ritchie et al., 2015; Jacquemet et al., 2019). Interestingly, we also
identified proteins that were functionally associated with M6a
in previous reports. For example, protein RUFY3 and neural
cell adhesion molecule 1 (NCAM1) are linked to M6a at the
early stage of neuron development (Sato et al., 2011). Whereas
glutamate ionotropic receptor, GRIN1 (also called NMDA-R1)
and synaptophysin (SYP) were functionally associated with M6a
at the synaptic cleft in a mature culture of hippocampal neurons
(Alfonso et al., 2005; Formoso et al., 2016; Garcia et al., 2017;
cream dots in Figure 2D). Hereafter, we characterized the global
protein pattern using the list of 414 genes (Supplementary
Table S2) as an input for the ToppGene Suite server2. Using
the ToppFun tool we performed GO and enrichment analysis to
prioritize statistically significant genes (Chen et al., 2009). The
top five GO function categories of these proteins are shown in
Figure 3 and Supplementary Table S3. Regarding the biological
processes category, enrichment analysis showed that the most
significant enrichment was for proteins involved in ‘‘synaptic
transmission’’ and ‘‘synaptic signaling.’’ This correlates with
the GO enrichment of the ‘‘cellular component’’ category in
which most proteins were significantly identified in ‘‘synapse,’’
‘‘cell junction,’’ ‘‘postsynapse,’’ ‘‘neuron projection’’ and ‘‘myelin
sheath’’ compartments. In the case of the ‘‘molecular function’’
category, the most significant terms displayed are related to
binding proteins.
Subsequently, we manually curated the 414 listed proteins
based on literature and subcellular localization annotation
according to the UniProt database1. We excluded proteins
localized in nucleus, cytosol or organelles (Golgi apparatus,
mitochondria, and endoplasmic reticulum), whereas we kept
proteins placed in the plasma membrane, extracellular matrix,
synaptic vesicles membranes or secreted ones (Végh et al.,
2014; Jacquemet et al., 2019; Lleó et al., 2019). Thus, the
remaining list of 72 proteins, due to their subcellular localization,
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FIGURE 3 | GO enrichment analysis. GO enrichment analysis of the
414 optimal interacting proteins. The analysis was done with the ToppFun
application of the ToppGene Suit server. The plot shows the top
five categories in which the proteins were classified for each category
analyzed: “Molecular function,” “Biological process,” and “Cellular
component.”
might interact with the extracellular loops of M6a. Figure 4
shows a heatmap of the abundance ratio of each protein in
each co-IP compared to their corresponding Mock condition.
The heatmap color scale is shown in the left upper corner,
with red being high and sky blue being low levels. The white
square represents samples with no signal available (NA). We
performed a new GO enrichment analysis with the 72 M6a’s
potential interactors using the ToppFun tool and the results
are shown in Table 1 (details in Supplementary Table S4).
Again, the top five GO annotations are significantly related
to synaptic transmission/signaling associated with proteins,
mainly ion transporters, on both sides of the synaptic cleft.
Using the same approach we also identified and prioritized
novel disease candidate genes within the 72 proteins by
ToppGene Suite server throughout a DisGeNET database4.
The results are summarized in Table 2. Interestingly, in
the top 10 diseases ‘‘Schizophrenia,’’ ‘‘Alzheimer’s Disease,’’
‘‘Depressive Disorder, ‘‘Major Depressive Disorder,’’ ‘‘Bipolar
Disorders,’’ and ‘‘Mental Depression’’ were found, which have
already been associated with glycoprotein M6a (Boks et al.,
2008; Greenwood et al., 2012; El-Kordi et al., 2013; Gregor
4http://www.disgenet.org/
et al., 2014; Fuchsova et al., 2015; Lachén-Montes et al., 2016;
Jacquemet et al., 2019).
Confirmation by Immunostaining
Based on their subcellular localization and being part of the most
represented cellular-component observed in the enrichment
analysis, four proteins were selected to confirm whether or
not they may interact with M6a (shown as green dots in
Figure 2D). Forty-nine percent of the proteins are located in the
synapse, with the majority of them (35/45) being pre-synaptic
proteins. Thus, we selected one protein from the synaptic
vesicle membrane (SV2B), one from the cytomatrix (PCLO) and
one that coats synaptic vesicles (SYN1). In third place, 28%
of the proteins were assigned to the ‘‘myelin sheath’’ cellular
compartment, so we also selected the oligodendrocyte cell surface
protein PLP for colocalization assays. In previous work, we
determined that M6a and transferrin receptor, TfR or TFRC,
share the same clathrin dependent-endocytic pathway (Garcia
et al., 2017). Nonetheless, TFRC was excluded from subsequent
analyses due to low relative abundance (average.top.3) of 6,6 and
a log2FC of 2.05. Thus, TfR was considered as a negative
control in the colocalization assays (TFRC, the blue dot in
Figure 2D).
M6a Interacts With Synaptic Proteins
Axon terminals—pre-synaptic compartment—form multiple
synaptic contacts with the cell soma and dendrites—post-
synaptic compartment—of another neuron aided by adhesion
molecules that interact across the synaptic cleft (Scheiffele,
2003; Sytnyk et al., 2004; Biederer and Scheiffele, 2007).
These specialized junctions between neurons can be easily
identified and quantified as the number of colocalization of
immunoreactive synaptic clustered proteins along dendrites in
cultured neurons (Dzyubenko et al., 2016; Verstraelen et al.,
2018). Thus, we examined whether M6a might associate with
the selected synaptic proteins by immunostaining primary
hippocampal neurons at 12–15 DIV with the appropriate
antibodies. Piccolo, synapsin 1 and the synaptic vesicle
glycoprotein 2B-SV2B-exhibit a normal pre-synaptic polarity,
meaning these proteins become preferentially accumulated, in
a punctate manner, in axon terminals (Fletcher et al., 1991;
Leal-Ortiz et al., 2008; Terry-Lorenzo et al., 2016; Bartholome
et al., 2017). Regarding M6a, we previously determined that
it is distributed along the neuronal surface within both pre-
and post-synaptic compartments as discrete puncta (Formoso
et al., 2016). Therefore, we first selected microscopic fields in
which pre-synaptic positive axon terminals were contacting
the secondary/tertiary dendrite of another neuron. Second, we
quantified the puncta colocalization between M6a puncta and
PCLO or SYN1 or SV2B puncta. Considering the punctate
distribution of the synaptic proteins, the Puncta Analyzer
plugin of ImageJ—which measures colocalization by an
object-based method—was used (Ippolito and Eroglu, 2010;
Dunn et al., 2011). Figures 5A–C shows a representative
image of each condition and the output obtained from
the Puncta Analyzer plugin as black squares (arrows and
magnified insets). Figure 5A shows a representative image
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FIGURE 4 | Heat map representation of the 72 differentially abundance proteins. The heat map shows the abundance of each protein in each co-IP (and replicates)
compare to the control condition (Mock). In the color scale, sky blue represents proteins with low levels, and red represents proteins with high levels of abundance.
White spots represent proteins with no signal available (NA).
of a 14 DIV hippocampal neuron and its magnification
(25 µm of secondary and tertiary dendrites length), where
we observed dots of colocalization (white with a black
square) between M6a puncta (magenta) and piccolo puncta
(green). Figure 5B shows a representative image of tertiary
dendrite and its magnification in which we observed dots of
colocalization (white with black squares) between clusters of
endogenous M6a (magenta with black squares) with clusters
of synapsin 1 (green with black squares). Here again, the
white color of overlapping between M6a puncta (magenta
with black squares) and SV2B puncta (green with black
squares) was also observed along the secondary dendrite in
the representative hippocampal neuron in Figure 5C (for
more details see Supplementary Figure S3). By contrast, no
colocalization pattern was observed between M6a (magenta) and
endogenous transferrin receptor (green) at the soma and along
the dendrites of the neuron (Figure 5D). Considering the TFRC
staining distribution, we quantified the possible colocalization
by an intensity-based method using the Coloc2 plugin of
ImageJ (Bolte and Cordelieres, 2006). At least three regions
of interest per cell were defined in the cell surface and
analyzed. The average of Pearson’s coefficient between
both proteins was −0.238 ± 0.039 (n = 15 cells) supporting
previous observation. Taken together, as retrieved by co-IP-
TMT/MS followed by bioinformatics tools we corroborated
the colocalization between M6a and the pre-synaptic
markers assessed.
M6a Interacts With the Major Myelin Protein—PLP
Proteolipid protein, PLP, is the most abundant integral
membrane protein of the CNS and expresses mainly in
oligodendrocytes (Lüders et al., 2019). We further investigated
whether M6a associates with PLP in the plasma membrane
of co-transfected neuroblastoma N2a cells. Thus, N2a
cells were transiently co-transfected with M6a tagged
with RFP (M6a-RFP)/PLP tagged with GFP (PLP-GFP) or
M6a-RFP/TfR-GFP. As it is shown in Figure 4E, PLP (green)
is an integral component of the cell surface, however, it
is also localized in the lysosome as storage compartment
(Winterstein et al., 2008). M6a (magenta) overexpressing N2a
cells showed a similar distribution that was described in neurons.
A colocalization pattern (white arrows in the insets of 5× 5µm),
like patches, all along the cell membrane, and cell protrusions
were observed between both proteins. Conversely, no color
superposition was observed in the cell surface and processes
of M6a/TfR-coexpressing N2a cells (Figure 5F). Taking into
consideration that the most common scenario is that M6a and
PLP associate in trans, which means cell-cell (neuron-glia)
interaction, we designed a co-culture experiment. Thus, two
pools of cells separately transfected with PLP-GFP and M6a-RFP
were used. Transfected pool cells were then mixed and allowed to
interact for 3 h and then were subjected to immunofluorescence.
Figure 5G reveals patches of colocalization (white in the
magnification) between both cell surface protrusions. Here
again, a quantitative estimation of colocalization was performed
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TABLE 1 | Gene ontology (GO) enrichment analysis of 72 potential M6a’s interactors.
























Nrxn3, Sv2b, Sv2a, Anxa5,
Scn2a, Syngr3, Syn1, Slc17a7,
Grin1, Ttyh3, Snap25, Atp1a1,































7.159E-19 6.916E-17 4.674E-16 3.458E-16 35 (49%) Gja1, Atp6v1a, Dpp6,
Atp6v1b2 Atp6v1c1, Atp6v1e1,
Stx1a, Atp6v1g2, Atp6v1h,
Atp6v0a1, Nrxn3, Sv2b, Sv2a,
Anxa5, Scn2a, Slc17a7, Grin1,
Ttyh3, Snap25, Atp1a1,










2.463E-20 2.819E-17 2.373E-16 6.274E-17 31 (43%) Dpp6, Nptn, Cpne6, Stx1a,
Nrxn3, Stxbp1, Synj1, Cadps,
Sv2b, Sv2a, Pclo, Scn2a,
Cntnap1, Syn1, Slc17a7, Syn2,
Syp, Syt1, Grin1, Snap25,
Atp1a2, App, Bsn, Grm1, Plp1,





2.463E-20 2.819E-17 2.373E-16 6.274E-17 31 (43%) Dpp6, Nptn, Cpne6, Stx1a,
Nrxn3, Stxbp1, Synj1, Cadps,
Sv2b, Sv2a, Pclo, Scn2a,
Cntnap1, Syn1, Slc17a7, Syn2,
Syp, Syt1, Grin1, Snap25,
Atp1a2, App, Bsn, Grm1, Plp1,
Slc1a2, Atp2b2, Slc1a3, Cnp,
Vdac1, Slc12a5
(Continued)
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3.319E-20 2.819E-17 2.373E-16 8.456E-17 31 (43%) Dpp6, Nptn, Cpne6, Stx1a,
Nrxn3, Stxbp1, Synj1, Cadps,
Sv2b, Sv2a, Pclo, Scn2a,
Cntnap1, Syn1, Slc17a7, Syn2,
Syp, Syt1, Grin1, Snap25,
Atp1a2, App, Bsn, Grm1, Plp1,




5.078E-20 3.235E-17 2.724E-16 1.294E-16 31 (43%) Dpp6, Nptn, Cpne6, Stx1a,
Nrxn3, Stxbp1, Synj1, Cadps,
Sv2b, Sv2a, Pclo, Scn2a,
Cntnap1, Syn1, Slc17a7, Syn2,
Syp, Syt1, Grin1, Snap25,
Atp1a2, App, Bsn, Grm1, Plp1,

















GO:0045202 synapse 1.406E-30 5.552E-28 3.641E-27 5.552E-28 45 (63%) Nptn, Dpysl2, Dpysl3, Stx1a,
Atp6v1g2, Atp6v0a1, Nrxn3,
Stxbp1, Nckap1, Synj1,
Scamp5, Cadps, Sv2b, Sv2a,
Anxa5, Pclo, Scn2a, Ncan,
Syngr3, Cntnap1, Syn1,
Slc17a7, Syn2, Syp, Syt1,
Bcan, Grin1, Snap25, Atp1a1,
Atp1a2, Atp1a3, App, Bsn,
Grm1, Epb41l3, Atp2b1, Eno2,
Slc1a2, Atp2b2, Slc1a3,
Atp2b4, Epb41, Cntn1, Slc3a2,
Vdac1
GO:0098793 presynapse 2.191E-29 4.328E-27 2.838E-26 8.656E-27 35 (49%) Nptn, Dpysl2, Stx1a, Atp6v1g2,
Atp6v0a1, Nrxn3, Stxbp1,
Synj1, Scamp5, Cadps, Sv2b,
Sv2a, Anxa5, Pclo, Scn2a,
Syngr3, Cntnap1, Syn1,
Slc17a7, Syn2, Syp, Syt1,
Grin1, Snap25, Atp1a2,
Atp1a3, App, Bsn, Grm1,
Atp2b1, Slc1a2, Atp2b2,
Atp2b4, Cntn1, Vdac1
GO:0043209 myelin sheath 1.714E-20 2.257E-18 1.48E-17 6.772E-18 21 (28%) Atp6v1a, Atp6v1b2, Dpysl2,
Stxbp1, Thy1, Cntnap1, Syn1,
Syn2, Snap25, Atp1a1,
Atp1a3, Atp1b1, Ppia, Eno2,
Plp1, Omg, Cnp, Mog, Cntn1,
Hsp90, Vdac1
GO:0030054 cell junction 1.073E-19 1.052E-17 6.89E-17 4.208E-17 35 (63%) Vapa, Gja1, Stx1a, Thy1,
Nckap1, Scamp5, Cadps,
Sv2b, Tnc, Sv2a, Anxa5, Pclo,
Scn2a, Syngr3, Cntnap1, Lrp1,
(Continued)
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Syn1, Slc17a7, Syn2, Syp,
Syt1, Grin1, Snap25, Atp1a1,
Atp1a2, App, Bsn, Epb41l3,




2.962E-19 2.925E-17 1.918E-16 1.17E-16 37 (51%) Nptn, Dpysl2, Dpysl3, Cpne6,
Stx1a, Stxbp1, Thy1, Rnpep,
Synj1, Sv2b, Sv2a, Anxa5,
Pclo, Scn2a, Cntnap1, Lrp1,
Syn1, Slc17a7, Syp, Syt1,
Bcan, Grin1, Snap25, Atp1a2,




The table shows the top five GO classification for each category analyzed: “Molecular function,” “Biological process” and “Cellular component.” The analysis was done with the ToppFun
application of the ToppGene Suit server.
using the Coloc2 plugin. Pearson coefficient’s between M6a and
PLP was 0.520 ± 0.047 (n = 13 cells) and between M6a and TfR
was 0.048± 0.032 (n = 25 cells). The Mander’s coefficients above
the threshold between M6a (red channel, M2) and PLP (green
channel, M1) were plotted in Figure 5F showing a high level of
overlap between both fluorescence signals. In summary, as in
the case of synaptic markers, the results support the association
between M6a and PLP.
DISCUSSION
The cellular and molecular mechanisms governing the formation
of synapses and developmental plasticity, including the roles
of cell-cell recognition molecules, cell adhesion molecules,
growth factors, electrical activity among others are critical
for the normal brain development. The relationship between
cells and their surroundings is markedly mediated by proteins
expressed on the cell surface. Despite the functional role of
the M6a’s extracellular loops, there is still no evidence about
physiological partners. In this work, we used a co-IP-TMT/MS
approach followed by bioinformatics analysis, and we identified
72 potential M6a’s interactors of which four proteins were
confirmed by colocalization.
We recently reported that the extracellular loops of M6a
and cysteine residues within the EC2 play a critical role for
M6a folding, trafficking and neuronal plasticity (Lagenaur et al.,
1992; Fuchsova et al., 2009; Formoso et al., 2016; Garcia
et al., 2017). In this sense, tetraspanins are a large family
of proteins in which the EC2 is a critical domain involved
in the specific intermolecular interactions (van Deventer
et al., 2017). Moreover, the high-resolution cryoelectron
microscopy structure of the tetraspanin protein family showed
that the EC1 domain packs in under the EC2 domain
(extracellular primary interaction). After, the EC1-EC2 binds
to the extracellular region of the partner protein (secondary
interaction) across the hypervariable region of EC2 (Min et al.,
2006). Likewise, proteolipid protein family (PLP1/DM20, M6a,
and M6b) structure are somewhat similar to tetraspanins,
and, therefore, a few studies have characterized the specific
binding sequences of PLPs to their partners, arguing that
their EC2 acts as a determinant site (Lagenaur et al., 1992;
Dhaunchak and Nave, 2007; Winterstein et al., 2008; Dhaunchak
et al., 2011; Sato et al., 2011; Formoso et al., 2015a). In
this work, to discover M6a ligands/partners we successfully
cloned, expressed and characterized a chimera protein that
contained both M6a’s extracellular loops (M6a-loops). A similar
approach, immunoprecipitation followed by mass spectrometry,
has been used to describe the association of tetraspanin
CD9 with the major histocompatibility complex MHC class
II molecule, α6b1 integrin, and CD44 in the cell surface of
B-lymphoid and platelets cells (Le Naour et al., 2004). Regarding
M6a (Honda et al., 2017), using co-IP followed by mass
spectrometry identified nine proteins (GPM6A, GPM6B, Sez6l2,
Lyric, TMEM30A, Xpr1, Tpbgl, Creld1, and Fndc3a) from
FLAG-tagged full M6a overexpressing HEK293 cells. Apart from
GPM6A (here, 6,9/3,0 average.top3/log2FC, Supplementary
Table S2), none of them were confirmed by our approach.
Nevertheless, the oligomerization of M6a in cell surface
from rat hippocampi and cultured neurons has been already
proven (Formoso et al., 2015b). However, when (Honda
et al., 2017) co-immunoprecipitated Triton X-100 extracts
from mice neuronal growth cone membrane fractions using
M6a-mAb; they identified and confirmed by immunostaining
the endogenous association between M6a and Rufy3. Despite
having identified Rufy3 (3,07/7,3; Figure 2D), it was cut
off from the analysis because of its subcellular localization,
which would suggest a direct interaction with the M6a
cytoplasmic tails instead of its extracellular domains. We
speculate that M6a-loops interacted, under non-reducing
conditions, with endogenous M6a (see Supplementary Figure
S2) and altogether co-precipitated with its C- and N-tails
partners. This could also explain why clathrin, coronin 1A,
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TABLE 2 | Disease-associated gene analysis of the 72 potential M6a’s interactors.






1.84E-10 3.041E-07 2.43E-06 3.041E-07 20 (27%) Gja1, Dpysl2, Stx1a, Nrxn3,
Stxbp1, Thy1, Scamp5, Tnc,
Pclo, Scn2a, Cntnap1, Syn1,
Syn2, Snap25, App, Aqp4,
Plp1, Slc1a2, Atp2b2, Slc1a3
C0014544 Epilepsy 1.05E-09 8.625E-07 6.89E-06 1.73E-06 19 (26%) Gja1, Dpysl3, Stx1a, Stxbp1,
Sv2a, Scn2a, Syn1, Slc17a7,
Syn2, Grin1, Atp1a2, Atp1a3,
App, Grm1, Aqp4, Slc1a2,
Slc1a3, Vdac1, Slc12a5
C0036341 Schizophrenia 2.40E-09 1.32E-06 1.05E-05 3.96E-06 28 (38%) Nptn, Dpysl2, Stx1a, Nrxn3,
Stxbp1, Sv2a, Pclo, Scn2a,
Ncan, Lrp1, Syn1, Slc17a7,
Syn2, Syp, Bcan, Grin1,
Snap25, App, Grm1, Ppia,
Aqp4, Eno2, Plp1, Slc1a2,
Slc1a3, Cnp, Mog, Slc12a5
C0002395 Alzheimer’s
Disease
2.10E-05 6.93E-03 0.055 0.035 26 (34%) Gja1, Dpysl2, Dpysl3, Thy1,
Synj1, Sv2a, Anxa5, Lrp1,
Syn1, Slc17a7, Syn2, Syp,
Syt1, Bcan, Grin1, Snap25,
App, Ppia, Aqp4, Eno2, Slc1a2,








2.61E-05 7.18E-03 0.057 0.043 16 (22%) Vapa, Dpysl2, Synj1, Pclo,
Ncan, Slc17a7, Syn2, Syp,
Grin1, Snap25, Atp1a1,
Atp1a2, Atp1a3, App, Slc1a2,
Slc1a3
C0036572 Seizures 4.81E-05 0.010 0.081 0.079 14 (19%) Gja1, Stxbp1, Synj1, Sv2a,
Scn2a, Slc17a7, Syn2, Grin1,




4.92E-05 0.010 0.081 0.081 14 (19%) Gja1, Dpysl2, Pclo, Syn1, Syp,
Grin1, Snap25, Atp1a3, App,





1.27E-04 2.11E-02 1.70E-01 2.19E-01 13 (19%) Gja1, Pclo, Ncan, Lrp1,
Slc17a7, Snap25, App, Plp1,




1.28E-04 0.022 0.176 0.211 14 (19%) Gja1, Dpysl2, Pclo, Syn1, Syp,
Grin1, Snap25, Atp1a3, App,
Grm1, Aqp4, Slc1a2, Cnp,
Hsp90
The table shows the overlap of the associated genes in the top 10 diseases. The analysis was done with the ToppFun application of the ToppGene Suit using data sourced
from DisGeNET.
HSP70, Src kinase family, phosphatidylinositide 3-kinase, Rab-
5, Rab-7, Rab-11, Rac-1/PaK, HIP14, PSMC5, and PKC were
identified (Supplementary Tables S1, S2), which have been
associated with M6a signal transduction, traffic and function
(Mukobata et al., 2002; Sato et al., 2011; Scorticati et al.,
2011; Butland et al., 2014; Formoso et al., 2015a; Fuchsova
et al., 2015; Alvarez Juliá et al., 2016; Garcia et al., 2017;
Ramachandran and Margolis, 2017).
In previous work we demonstrated that M6a plays a role
in synapse formation and maintenance; increasing the number
of clusters of the pre-synaptic component synaptophysin (SYP)
and the post-synaptic component glutamate receptor ionotropic
NMDA-R1 (GRIN1, Formoso et al., 2016). Notably, 45 of the
curated proteins, approximately 63% of total, were classified by
their cellular component as ‘‘synapse’’ (GO:0045202, Table 1) in
which 35 were ‘‘presynapse’’ (GO:0098793: Nptn, Dpysl2, Stx1a,
Atp6v1g2, Atp6v0a1, Nrxn3, Stxbp1, Synj1, Scamp5, Cadps,
Sv2b, Sv2a, Anxa5, Pclo, Scn2a, Syngr3, Cntnap1, Syn1, Slc17a7,
Syn2, Syp, Syt1, Grin1, Snap25, Atp1a2, Atp1a3, App, Bsn,
Grm1, Atp2b1, Slc1a2, Atp2b2, Atp2b4, Cntn1, Vdac1) and
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FIGURE 5 | M6a interacts with synaptic proteins and with major myelin protein, PLP. (A–D) Representative images of primary hippocampal cultured neurons at
14 DIV. Neurons were labeled for endogenous M6a (gray or magenta in the insets) and endogenous piccolo (A), synapsin 1 (B), SV2B (C), and TfR ((D; gray and
green in the insets). The magnifications show 25 µm of primary (C,D), secondary (A), and tertiary (A,B) dendrite length. Punta Analyzer plugin of ImageJ was used to
measure the colocalization between M6a and synaptic markers. Puncta Analyzer displayed images such as the ones shown here in which colocalization puncta are
indicated by black squares (inset). Merged images show clusters of M6a colocalizing with clusters of piccolo (A) or synapsin-1 (B) and SV2B (C; with arrows and
black squares). Scale bar: 10 µm. (E,F) Representative images of murine neuroblastoma N2a cells co-transfected with M6a-RFP/PLP-GFP (E) and
M6a-RFP/TfR-GFP (F). The insets (5 × 5 µm) show the pattern of distribution of M6a-RFP (magenta) and PLP-GFP or TfR-GFP (green) and the merged images
show colocalization between M6a-RFP and PLP-GFP (E, white arrows), but not between M6a-RFP and TfR-GFP. (G) Representative images of co-culture
experiment between cells that only expressed PLP-GFP and cells that only expressed M6a-RFP. The magnification (5 × 10 µm) reveals patches of colocalization
(white) between both cell surfaces. Scale bar: 5 µm. Confocal images were acquired with a 60× objective on an Olympus FV1000 confocal microscope. The
colocalization between M6a and TfR or PLP was measured by the Coloc2 plugin of ImageJ. For those pairs of proteins positive for colocalization (average of
Pearson’s coefficient over than 0.5). Mander’s coefficients (M1, green channel and M2, red channel) were measured and plotted (n = 13–25 cells). No positive
Pearson’s coefficients of colocalization between endogenous M6a and TfR or M6a-RFP and TfR-GFP were measured.
37 were part of ‘‘neuron projection’’ (GO:0043005: Nptn, Dpysl2,
Dpysl3, Cpne6, Stx1a, Stxbp1, Thy1, Rnpep, Synj1, Sv2b, Sv2a,
Anxa5, Pclo, Scn2a, Cntnap1, Lrp1, Syn1, Slc17a7, Syp, Syt1,
Bcan, Grin1, Snap25, Atp1a2, Atp1a3, App, Bsn, Grm1, Epb41l3,
Atp2b1, Eno2, Slc1a2, Atp2b2, Slc1a3, Atp2b4, Hsp90, Slc12a5).
Here, we confirmed by immunostaining the association between
endogenous M6a and piccolo (PCLO 2,7/7,9; Figure 2D),
synaptic vesicle protein 2 B (SV2B 3,0/7,5; Figure 2D) and
synapsin 1 (SYN1, 2,7/8,2; Figure 2D) in rat neuronal cultures of
14 DIV (Figures 5A–D). M6a has been isolated frommembranes
of synaptic vesicles of the adult rat brain (Takamori et al., 2006).
Thus, M6a located at the surface of the synaptic vesicle might
interact with SV2B in cis in the same vesicle or transwith a vesicle
in its neighborhood. In the same context, M6a might interact
with the scaffold proteins of the presynaptic cytomatrix at the
active zone, piccolo, and synapsin 1.
Although the interaction between M6a with pre-synaptic
receptors such as the µ-opioid receptor, cannabinoid receptor
CB1, and somatostatin receptor sst2A was documented, they
were ruled out from our study (Wu et al., 2007). Moreover, in the
same work, the association between M6a and the metabotropic
glutamate receptor 1 (here GRM1, 3,1/7,0; Figure 2D) was
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excluded by bioluminescence resonance energy transfer (BRET)
assay in cells transiently transfected with both proteins. This
could be explained because the authors use a truncated form of
M6a (108-278M6a) lacking N-tail, TMD1, and EC1- interactions
from their assays.
Among others, 21 of the selected proteins (28%) were
annotated as part of the ‘‘myelin sheath’’ (GO:0043209:
Atp6v1a, Atp6v1b2, Dpysl2, Stxbp1, Thy1, Cntnap1, Syn1,
Syn2, Snap25, Atp1a1, Atp1a3, Atp1b1, Ppia, Eno2, Plp1,
Omg, Cnp, Mog, Cntn1, Hsp90, Vdac1). Therefore, M6a may
interact with membrane proteins expressed on the surface of
CNS oligodendrocytes. By immunostaining, we confirmed the
association between M6a and PLP in co-expressing N2a cells
(cis interaction) and co-culture experiment (trans interaction;
Figures 5E–G). Remarkably, M6b was identified as a Schwann
cell microvilli component that stabilizes the nodes of Ranvier
by its association with glial gliomedin, CNTNAP1 (here 2,6/7,8),
glial NrCAM (here 2,1/8,0), and axonal NF186 (here 3,5/6,8) in
a co-culture of dorsal root ganglion neurons and Schwann cells
(Bang et al., 2018). Although, there is no evidence supporting the
role of M6a in the peripheral nervous system; our data suggest
that M6a could participate as a regulator of sensory neuron and
glia interactions.
In this work, with an integrative platform (DisGeNET) by
which human-disease associated genes and variants are classified,
the final 72 proteins were analyzed (Piñero et al., 2017). Not
surprisingly, the analysis displayed the names of disorders that
have been already linked to GPM6A altered expression or
GPM6A genetic variants in human or animal models of diseases
(Alfonso et al., 2002, 2004, 2005; Greenwood et al., 2012; El-Kordi
et al., 2013; Penzes et al., 2013; Gregor et al., 2014; Formoso et al.,
2015b; Fuchsova et al., 2015; Mita et al., 2015; Lachén-Montes
et al., 2016). Moreover, new terms such as ‘‘autistic disorder,’’
‘‘epilepsy’’ and, ‘‘seizures’’ were found, suggesting a new role of
M6a in these disorders.
In summary, the main aim of this project was to augment
the comprehension of the molecular mechanisms linked
to neuronal plasticity and thus improve the assessment,
diagnosis, and treatment of many nervous system disorders
among others. Fluorescence immunocytochemistry followed
by quantification of protein colocalization is an indirect
technique for determining protein-protein interaction.
Hence, experiments like in situ proximity ligation assay,
PLA (Alam, 2018; Almandoz-Gil et al., 2018), which confirm
the direct interaction between two proteins are needed for the
final validation of our study. Besides, experiments focused on
the functional implication of the potential M6a’s interactors
are convenient to understand the integral role of M6a in the
neuronal development and the neurobiology of the diseases.
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